daniel drucker glp 1 highlights power and limits of GLP1 medicines in Lefkowitz Distinguished Lecture Canadian lab explains puzzling link

Its limitation is equally important

Standard management of these adverse effects typically involves symptomatic treatment for acute presentations, such as antiemetics and intravenous fluids, followed by patient-directed non-pharmacologic strategies (smaller meals, slower eating, increased meal frequency) and prescriber-directed pharmacologic adjustments (slower titration, temporary interruption, dose reduction) [29]

CRP (C-Reactive Protein): This is a key marker of systemic inflammation

The figure is conceptual in nature and was developed by the authors based on previously published literature on circadian aging

That being said, most people don't train nearly hard enough